September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Impact of TMB, PD-L1 , genomic features, and pneumonitis on CRT and durvalumab response in stage III NSCLC – João Alessi
Jul 19, 2023, 18:03

Impact of TMB, PD-L1 , genomic features, and pneumonitis on CRT and durvalumab response in stage III NSCLC – João Alessi

Glad to share our paper recently published in Nature. In which, we report the impact of TMB, PD-L1 , genomic features, and pneumonitis on CRT and durvalumab response in stage III NSCLC. Collaboration b/w Dana-Farber and Memorial Sloan Kettering Radiation Oncology.

For article: Click here

Source: João Alessi/Twitter